<- Go Home
ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.
Market Cap
$75.5M
Volume
315.5K
Cash and Equivalents
$86.3M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$7.88
52 Week Low
$1.40
Dividend
N/A
Price / Book Value
0.66
Price / Earnings
-2.65
Price / Tangible Book Value
0.66
Enterprise Value
-$38.1M
Enterprise Value / EBITDA
1.15
Operating Income
-$33.4M
Return on Equity
23.07%
Return on Assets
-16.48
Cash and Short Term Investments
$113.9M
Debt
$280.2K
Equity
$113.5M
Revenue
N/A
Unlevered FCF
-$14.7M
Sector
Biotechnology
Category
N/A